1026522-99-5

Upstream product

• 50893-53-3 carbonochloridic acid 1-chloro-ethyl ester 
• 182068-07-1 2-Ethoxy-N-[4-(4-fluoro-benzyl)-morpholin-2-ylmethyl]-3-hydroxy-4-nitro-benzamide 
• 112914-13-3 2-aminomethyl-4-(4-fluoro-benzyl) morpholine 
• 182067-60-3 2-ethoxy-3-hydroxy-4-nitrobenzoic acid 
• 182068-21-9 2-ethoxy-3-hydroxy-4-nitrobenzoyl chloride 
• 182067-54-5 2-ethoxy-3-hydroxy-4-nitrobenzaldehyde 
• 182067-51-2 2-ethoxy-3-hydroxybenzaldehyde 
• 24677-78-9 2,3-dihydroxybenzaldehyde 

Downstream Products

• 182068-17-3 2-[(4-Acetylamino-5-chloro-2-ethoxy-3-hydroxy-benzoylamino)-methyl]-morpholine-4-carboxylic acid tert-butyl ester 
• 182068-12-8 2-[(2-Ethoxy-3-hydroxy-4-nitro-benzoylamino)-methyl]-morpholine-4-carboxylic acid tert-butyl ester 
• 182068-15-1 2-[(4-Acetylamino-2-ethoxy-3-hydroxy-benzoylamino)-methyl]-morpholine-4-carboxylic acid tert-butyl ester 
• 1027595-24-9 2-ethoxy-3-hydroxy-N-(2-morpholinylmethyl)-4-nitrobenzamide 

Relevant academic research and scientific papers

Synthesis and biological activity of 4-amino-5-chloro-2-ethoxy-3- hydroxybenzamides, metabolites of a new gastroprokinetic agent, mosapride

To confirm the proposed structures of the minor metabolites of a potential gastroprokinetic agent, mosapride, 4-amino-5-chloro-2-ethoxy-3- hydroxy-N-(2-morpholinylmethyl)benzamide (3) and the N-(5-oxo-2- morpholinyl)methyl analogue 4 were prepared. As the